Trump’s DOJ moved medical cannabis to Schedule III on April 23. Here is exactly what changed, what did not, and what questions the order still has not answered.
Ensure your cannabis products meet the highest standards with transparent, accountable testing. Manipulated data and pay-to-pass testing compromise safety, quality, and industry growth.